Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients With Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)

NCT03292887 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03292887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients With Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
October 3, 2005
Completion date
February 16, 2023
Enrollment
1,443 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hunter syndrome